Collaboration

Publications & Docs

Correlation Network

Correlation goes harm reduction

Correlation - European Network on Social Inclusion and Health has changed its name. From now on we are:

Correlation was established in 2004, and has always worked in the field of drug use, harm reduction and social inclusion, by focusing on the needs of different marginalised groups. However, in the past years our activities were mainly targeting harm reduction policies and practice and we believe that it is necessary to have a strong and sustainable harm reduction network in Europe as well.

In the forthcoming months, we will launch a new website and update you on our aims, objectives and work plans. Last, but not least, we will let you know how you can get involved. To make harm reduction strong again, we need the input and the commitment of all of you!

We’d also like to take this opportunity to announce a couple of events, which will be organised by Correlation this year:

Hepatitis C Community Summit: 18 September 2018 - in cooperation with the INHSU conference in Lisbon.

The fourth European Harm Reduction Conference - after Marseille 2011, Basel and Amsterdam in 2014 – will be organised in cooperation with our Romanian partners and different European Networks and partners, such as Infodrug Switzerland, the European Network of People Who Use Drugs, the Eurasian Harm Reduction Association and the European Joint Action HA-REACT. More information on this event will follow soon! http://www.correlation-net.org/

Block these dates in your agenda and join the European Harm Reduction Movement.

Latest news:

Correlation Street Support Project published assessment report:

What works and what not to support homeless people

The report provides an overview of effective inclusive measures that reduce and prevent public nuisance caused by adult drug and/or alcohol users. While municipalities provide basic support for marginalized groups, it seems local governments are also using them as a way to rid the public space of unwanted marginalised groups, and moving this issue away from the public eye. Read more about hat kind of prerequisites are needed to develop and implement inclusive strategies

DCR involvement in HCV prevention and treatment is crucial. So what is their response and where are the needs?Uniting, Sydney and INDCR/Correlation Network published new report.

The report - based on an online survey under DCRs/SIFs worldwide - describes the range of services currently offered, the existing approaches to HCV awareness, prevention and treatment and what the needs are to improve and extend services.

Hepatitis C Testing in the Community

This paper highlights the benefits of community based testing which uses settings within affected and marginalized key populations to provide testing services.

European HIV Hepatitis Testing Week:

Get all info about Hepatitis testing, testing technologies,guidance for communication and downloadable info sheets and checklists at

Correlation Network, together with many other community organisations, signed a declaration on the elimination goals for hepatitis c in the light of continuous stigmatisation and decriminalisation of affected communities. Despite WHO recommendations identifying harm reduction as one of five core interventions to reach the goal of viral hepatitis elimination by 2030, in many countries, comprehensive harm reduction services continue to be largely inaccessible, with barriers to services driven by punitive drug law enforcement laws and policies.

You can read the full declaration

European HIV/HCV Testing Week - get support by Correlation

If your organisation is interested to participate in European HIV/HCV Testing Week, November 17 - 24, 2017 please let us know now. Correlation Network will support your organisation to participate by providing technical assistance, capacity building support, HCV trainings and we can give you a limited amount of Orasure oral HCV test kits.

Contact Jason Farrell This email address is being protected from spambots. You need JavaScript enabled to view it. orEberhard Schatz This email address is being protected from spambots. You need JavaScript enabled to view it. forrequest and consult

Correlation was part of a workshop in Gastein, Austria, on 4 October 2017 which brought representatives of many underserved groups – namely men who have sex with men (MSM), people who inject drugs (PWID), migrants, sex workers, prisoners and the homeless – together with policy experts and other conference participants to identify commonalities both in the barriers to care and the policy solutions.

To reinforce harm reduction efforts in the European region Correlation Network and Infodrog, the Swiss Office for the Coordination of Addiction Facilities, are planning to organise a meeting in Amsterdam on December 4, 2017. If you are interested to join that meeting and to take part in that process, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

Safe, voluntary testing for key and most affected populations

Correlation signed a joint statement from key population networks, regional networks, HIV and Hepatitis organisations.

Hepatitis B and C testing: why? Who? How?

A guidance paper on testing in community and harm reduction settings

This paper aims to stimulate services to engage in HCV and HBV awareness raising and in particular to inform community members, social and health care practitioners about current HBV/HCV testing and diagnosis methods, screening technologies and other aspects around the issue.

Hepatitis C Civil Society Declaration launched

At the Hepatitis C Community Summit in Amsterdam, civil society and community organisations from all over Europe launched a declaration to address the urgent need for civil society involvement in HCV policy and practice. Only with the collaboration of all and by combating stigma and discrimination, can the elimination of HCV be a realistic goal.

Correlation projects

With financial support of the European Commission, Programme of Community Action in the field of health. Neither the European Commission nor any person acting on its behalf is liable for any use of information contained in this publication.